{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:54:28Z","timestamp":1790373268188,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0701-z","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T15:55:07Z","timestamp":1446652507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis"],"prefix":"10.1186","volume":"13","author":[{"given":"Ruben","family":"Magni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Espina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketul","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lepene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Mayuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temple A.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Espina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Rucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Dunlap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel F. III","family":"Petricoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Frekko","family":"Kilavos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Poretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert R.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Shor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance A.","family":"Liotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"701_CR1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cll.2010.01.003","volume":"30","author":"TS Murray","year":"2010","unstructured":"Murray TS, Shapiro ED. Lyme disease. Clin Lab Med. 2010;30:311\u201328.","journal-title":"Clin Lab Med"},{"key":"701_CR2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0025-6196(11)60731-3","volume":"83","author":"RL Bratton","year":"2008","unstructured":"Bratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008;83:566\u201371.","journal-title":"Mayo Clin Proc"},{"key":"701_CR3","unstructured":"Bacon R, Kugeler K, Mead P. Centers for Disease Control and Prevention (CDC). Surveillance for Lyme disease\u2014United States, 1992\u20132006. Morb Mortal Wkly Rep (MMWR) 2008; 57:SS 1-10."},{"key":"701_CR4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","volume":"100","author":"RB Nadelman","year":"1996","unstructured":"Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, Aguero-Rosenfeld M, Wormser GP. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med. 1996;100:502\u20138.","journal-title":"Am J Med"},{"key":"701_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0002-9343(86)90185-3","volume":"81","author":"L Reik","year":"1986","unstructured":"Reik L, Burgdorfer W, Donaldson JO. Neurologic abnormalities in Lyme disease without erythema chronicum migrans. Am J Med. 1986;81:73\u20138.","journal-title":"Am J Med"},{"key":"701_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1473-3099(03)00722-9","volume":"3","author":"UR Hengge","year":"2003","unstructured":"Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis. 2003;3:489\u2013500.","journal-title":"Lancet Infect Dis"},{"key":"701_CR7","first-page":"1","volume":"57","author":"E Schneider","year":"2008","unstructured":"Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT. (CDC) CfDCaP: revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18\u00a0months and for HIV infection and AIDS among children aged 18\u00a0months to <13\u00a0years\u2013United States, 2008. MMWR Recomm Rep. 2008;57:1\u201312.","journal-title":"MMWR Recomm Rep"},{"key":"701_CR8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/1874205X01206010140","volume":"6","author":"ST Donta","year":"2012","unstructured":"Donta ST. Issues in the diagnosis and treatment of lyme disease. Open Neurol J. 2012;6:140\u20135.","journal-title":"Open Neurol J"},{"key":"701_CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10096-007-0342-0","volume":"26","author":"MF Seidel","year":"2007","unstructured":"Seidel MF, Domene AB, Vetter H. Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome. Eur J Clin Microbiol Infect Dis. 2007;26:611\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"701_CR10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2298\/MPNS1012839G","volume":"63","author":"O Gajovi\u0107","year":"2010","unstructured":"Gajovi\u0107 O, Todorovi\u0107 Z, Nesi\u0107 L, Lazi\u0107 Z. Lyme borreliosis\u2013diagnostic difficulties in interpreting serological results. Med Pregl. 2010;63:839\u201343.","journal-title":"Med Pregl"},{"key":"701_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/09674845.2011.11732834","volume":"68","author":"S Mavin","year":"2011","unstructured":"Mavin S, McDonagh S, Evans R, Milner RM, Chatterton JM, Ho-Yen DO. Interpretation criteria in Western blot diagnosis of Lyme borreliosis. Br J Biomed Sci. 2011;68:5\u201310.","journal-title":"Br J Biomed Sci"},{"key":"701_CR12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaad.2010.03.046","volume":"64","author":"C Bhate","year":"2011","unstructured":"Bhate C, Schwartz RA. Lyme disease: part I. Advances and perspectives. J Am Acad Dermatol. 2011;64:619\u201336 (quiz 637\u2013618).","journal-title":"J Am Acad Dermatol"},{"key":"701_CR13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01780661","volume":"24","author":"F Strle","year":"1996","unstructured":"Strle F, Maraspin V, Lotric-Furlan S, Ruzi\u0107-Sablji\u0107 E, Cimperman J. Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. Infection. 1996;24:64\u20138.","journal-title":"Infection"},{"key":"701_CR14","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1128\/IAI.71.7.3979-3987.2003","volume":"71","author":"I Diterich","year":"2003","unstructured":"Diterich I, Rauter C, Kirschning CJ, Hartung T. Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect Immun. 2003;71:3979\u201387.","journal-title":"Infect Immun"},{"key":"701_CR15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1600-0463.2010.02615.x","volume":"118","author":"H Yrj\u00e4n\u00e4inen","year":"2010","unstructured":"Yrj\u00e4n\u00e4inen H, Hyt\u00f6nen J, Hartiala P, Oksi J, Viljanen MK. Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment. APMIS. 2010;118:665\u201373.","journal-title":"APMIS"},{"key":"701_CR16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/374376","volume":"187","author":"M Peltomaa","year":"2003","unstructured":"Peltomaa M, McHugh G, Steere AC. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J Infect Dis. 2003;187:1178\u201386.","journal-title":"J Infect Dis"},{"key":"701_CR17","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1172\/JCI58813","volume":"122","author":"LK Bockenstedt","year":"2012","unstructured":"Bockenstedt LK, Gonzalez DG, Haberman AM, Belperron AA. Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy. J Clin Invest. 2012;122:2652\u201360.","journal-title":"J Clin Invest"},{"key":"701_CR18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/nl072174l","volume":"8","author":"A Luchini","year":"2008","unstructured":"Luchini A, Geho DH, Bishop B, Tran D, Xia C, Dufour RL, Jones CD, Espina V, Patanarut A, Zhou W, et al. Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation. Nano Lett. 2008;8:350\u201361.","journal-title":"Nano Lett"},{"key":"701_CR19","doi-asserted-by":"crossref","first-page":"19178","DOI":"10.1021\/ja207515j","volume":"133","author":"D Tamburro","year":"2011","unstructured":"Tamburro D, Fredolini C, Espina V, Douglas TA, Ranganathan A, Ilag L, Zhou W, Russo P, Espina BH, Muto G, et al. Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers. J Am Chem Soc. 2011;133:19178\u201388.","journal-title":"J Am Chem Soc"},{"key":"701_CR20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1172\/JCI117346","volume":"94","author":"SE Schutzer","year":"1994","unstructured":"Schutzer SE, Coyle PK, Dunn JJ, Luft BJ, Brunner M. Early and specific antibody response to OspA in Lyme disease. J Clin Invest. 1994;94:454\u20137.","journal-title":"J Clin Invest"},{"key":"701_CR21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1128\/JCM.32.3.777-782.1994","volume":"32","author":"LA Magnarelli","year":"1994","unstructured":"Magnarelli LA, Anderson JF, Stafford KC. Detection of Borrelia burgdorferi in urine of Peromyscus leucopus by inhibition enzyme-linked immunosorbent assay. J Clin Microbiol. 1994;32:777\u201382.","journal-title":"J Clin Microbiol"},{"key":"701_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00189424","volume":"181","author":"G Zumstein","year":"1992","unstructured":"Zumstein G, Fuchs R, Hofmann A, Preac-Mursic V, Soutschek E, Wilske B. Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi. Med Microbiol Immunol. 1992;181:57\u201370.","journal-title":"Med Microbiol Immunol"},{"issue":"Suppl 1","key":"701_CR23","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1086\/338463","volume":"185","author":"BJ Luft","year":"2002","unstructured":"Luft BJ, Dunn JJ, Lawson CL. Approaches toward the directed design of a vaccine against Borrelia burgdorferi. J Infect Dis. 2002;185(Suppl 1):S46\u201351.","journal-title":"J Infect Dis"},{"key":"701_CR24","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1128\/IAI.00410-08","volume":"76","author":"JM Battisti","year":"2008","unstructured":"Battisti JM, Bono JL, Rosa PA, Schrumpf ME, Schwan TG, Policastro PF. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector. Infect Immun. 2008;76:5228\u201337.","journal-title":"Infect Immun"},{"key":"701_CR25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/JCM.27.1.58-61.1989","volume":"27","author":"FW Hyde","year":"1989","unstructured":"Hyde FW, Johnson RC, White TJ, Shelburne CE. Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol. 1989;27:58\u201361.","journal-title":"J Clin Microbiol"},{"key":"701_CR26","doi-asserted-by":"crossref","first-page":"e17287","DOI":"10.1371\/journal.pone.0017287","volume":"6","author":"SE Schutzer","year":"2011","unstructured":"Schutzer SE, Angel TE, Liu T, Schepmoes AA, Clauss TR, Adkins JN, Camp DG, Holland BK, Bergquist J, Coyle PK, et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One. 2011;6:e17287.","journal-title":"PLoS One"},{"key":"701_CR27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9343(00)00701-4","volume":"110","author":"MS Klempner","year":"2001","unstructured":"Klempner MS, Schmid CH, Hu L, Steere AC, Johnson G, McCloud B, Noring R, Weinstein A. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med. 2001;110:217\u20139.","journal-title":"Am J Med"},{"key":"701_CR28","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/JCM.36.9.2658-2665.1998","volume":"36","author":"S Brettschneider","year":"1998","unstructured":"Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol. 1998;36:2658\u201365.","journal-title":"J Clin Microbiol"},{"key":"701_CR29","doi-asserted-by":"crossref","first-page":"e4763","DOI":"10.1371\/journal.pone.0004763","volume":"4","author":"C Longo","year":"2009","unstructured":"Longo C, Patanarut A, George T, Bishop B, Zhou W, Fredolini C, Ross MM, Espina V, Pellacani G, Petricoin EF 3rd, et al. Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers. PLoS One. 2009;4:e4763.","journal-title":"PLoS One"},{"key":"701_CR30","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.biomaterials.2010.10.004","volume":"32","author":"TA Douglas","year":"2011","unstructured":"Douglas TA, Tamburro D, Fredolini C, Espina BH, Lepene BS, Ilag L, Espina V, Petricoin EF, Liotta LA, Luchini A. The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease. Biomaterials. 2011;32:1157\u201366.","journal-title":"Biomaterials"},{"key":"701_CR31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/abio.1996.0364","volume":"240","author":"DL Mattson","year":"1996","unstructured":"Mattson DL, Bellehumeur TG. Comparison of three chemiluminescent horseradish peroxidase substrates for immunoblotting. Anal Biochem. 1996;240:306\u20138.","journal-title":"Anal Biochem"},{"key":"701_CR32","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul SF, Madden TL, Sch\u00e4ffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389\u2013402.","journal-title":"Nucleic Acids Res"},{"key":"701_CR33","volume-title":"Lyme disease: an evidence-based approach","author":"JBJ Johnson","year":"2011","unstructured":"Johnson JBJ. Laboratory diagnostic testing for Borrelia bugdorferi infection. In: Halperin JJ, editor. Lyme disease: an evidence-based approach. Oxfordshire: CAB International; 2011."},{"key":"701_CR34","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/14787210.2014.940900","volume":"12","author":"DJ Cameron","year":"2014","unstructured":"Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014;12:1103\u201335.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"701_CR35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089\u2013134.","journal-title":"Clin Infect Dis"},{"key":"701_CR36","unstructured":"Final Report of the Lyme Disease Review Panel of the Infectious Diseases Society of America (IDSA) ( http:\/\/www.idsociety.org\/Lyme_Final_Report\/ )."},{"key":"701_CR37","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1212\/WNL.37.11.1700","volume":"37","author":"JJ Halperin","year":"1987","unstructured":"Halperin JJ, Little BW, Coyle PK, Dattwyler RJ. Lyme disease: cause of a treatable peripheral neuropathy. Neurology. 1987;37:1700\u20136.","journal-title":"Neurology"},{"key":"701_CR38","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1212\/WNL.41.10.1571","volume":"41","author":"JJ Halperin","year":"1991","unstructured":"Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 1991;41:1571\u201382.","journal-title":"Neurology"},{"key":"701_CR39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/07853899909115982","volume":"31","author":"J Oksi","year":"1999","unstructured":"Oksi J, Marjam\u00e4ki M, Nikoskelainen J, Viljanen MK. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann Med. 1999;31:225\u201332.","journal-title":"Ann Med"},{"key":"701_CR40","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","volume":"121","author":"NA Shadick","year":"1994","unstructured":"Shadick NA, Phillips CB, Logigian EL, Steere AC, Kaplan RF, Berardi VP, Duray PH, Larson MG, Wright EA, Ginsburg KS, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med. 1994;121:560\u20137.","journal-title":"Ann Intern Med"},{"key":"701_CR41","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","volume":"323","author":"EL Logigian","year":"1990","unstructured":"Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323:1438\u201344.","journal-title":"N Engl J Med"},{"key":"701_CR42","first-page":"109","volume":"18","author":"S Shor","year":"2011","unstructured":"Shor S. Retrospective analysis of a cohort of internationally case defined chronic fatigue syndrome patients in a Lyme endemic area. Bulletin of the IACFS\/ME. 2011;18:109\u201323.","journal-title":"Bulletin of the IACFS\/ME"},{"key":"701_CR43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9343(90)90520-N","volume":"88","author":"LH Sigal","year":"1990","unstructured":"Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med. 1990;88:577\u201381.","journal-title":"Am J Med"},{"key":"701_CR44","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1001\/jama.1993.03500140064037","volume":"269","author":"AC Steere","year":"1993","unstructured":"Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA. 1993;269:1812\u20136.","journal-title":"JAMA"},{"key":"701_CR45","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.amjmed.2009.02.022","volume":"122","author":"AL Hassett","year":"2009","unstructured":"Hassett AL, Radvanski DC, Buyske S, Savage SV, Sigal LH. Psychiatric comorbidity and other psychological factors in patients with \u201cchronic Lyme disease\u201d. Am J Med. 2009;122:843\u201350.","journal-title":"Am J Med"},{"key":"701_CR46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00006454-200201000-00003","volume":"21","author":"MZ Qureshi","year":"2002","unstructured":"Qureshi MZ, New D, Zulqarni NJ, Nachman S. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J. 2002;21:12\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"701_CR47","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/000992289403301105","volume":"33","author":"CD Rose","year":"1994","unstructured":"Rose CD, Fawcett PT, Gibney KM, Doughty RA. The overdiagnosis of Lyme disease in children residing in an endemic area. Clin Pediatr (Phila). 1994;33:663\u20138.","journal-title":"Clin Pediatr (Phila)"},{"key":"701_CR48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1468-1331.2010.03229.x","volume":"18","author":"M Djukic","year":"2011","unstructured":"Djukic M, Schmidt-Samoa C, Nau R, von Steinb\u00fcchel N, Eiffert H, Schmidt H. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis\u2013the experience from 1\u00a0year of a university hospital\u2019s Lyme neuroborreliosis outpatients clinic. Eur J Neurol. 2011;18:547\u201355.","journal-title":"Eur J Neurol"},{"key":"701_CR49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/clind\/16.4.558","volume":"16","author":"DR Burdge","year":"1993","unstructured":"Burdge DR, O\u2019Hanlon DP. Experience at a referral center for patients with suspected Lyme disease in an area of nonendemicity: first 65 patients. Clin Infect Dis. 1993;16:558\u201360.","journal-title":"Clin Infect Dis"},{"key":"701_CR50","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","volume":"281","author":"DM Gross","year":"1998","unstructured":"Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 1998;281:703\u20136.","journal-title":"Science"},{"key":"701_CR51","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1128\/IAI.62.10.4632-4636.1994","volume":"62","author":"JJ Weis","year":"1994","unstructured":"Weis JJ, Ma Y, Erdile LF. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun. 1994;62:4632\u20136.","journal-title":"Infect Immun"},{"key":"701_CR52","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/PL00000641","volume":"57","author":"DM Gross","year":"2000","unstructured":"Gross DM, Huber BT. Cellular and molecular aspects of Lyme arthritis. Cell Mol Life Sci. 2000;57:1562\u20139.","journal-title":"Cell Mol Life Sci"},{"key":"701_CR53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.20031960","volume":"199","author":"XF Yang","year":"2004","unstructured":"Yang XF, Pal U, Alani SM, Fikrig E, Norgard MV. Essential role for OspA\/B in the life cycle of the Lyme disease spirochete. J Exp Med. 2004;199:641\u20138.","journal-title":"J Exp Med"},{"key":"701_CR54","doi-asserted-by":"crossref","unstructured":"Oosting M, Buffen K, van der Meer JW, Netea MG, Joosten LA. Innate immunity networks during infection with Borrelia burgdorferi. Crit Rev Microbiol 2014;1\u201312","DOI":"10.3109\/1040841X.2014.929563"},{"key":"701_CR55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.183.1.271","volume":"183","author":"AM Silva de","year":"1996","unstructured":"de Silva AM, Telford SR, Brunet LR, Barthold SW, Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med. 1996;183:271\u20135.","journal-title":"J Exp Med"},{"key":"701_CR56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/JCM.38.1.382-388.2000","volume":"38","author":"TG Schwan","year":"2000","unstructured":"Schwan TG, Piesman J. Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol. 2000;38:382\u20138.","journal-title":"J Clin Microbiol"},{"key":"701_CR57","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1128\/IAI.71.7.4003-4010.2003","volume":"71","author":"H Crowley","year":"2003","unstructured":"Crowley H, Huber BT. Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect Immun. 2003;71:4003\u201310.","journal-title":"Infect Immun"},{"key":"701_CR58","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/IAI.61.7.2774-2779.1993","volume":"61","author":"RA Kalish","year":"1993","unstructured":"Kalish RA, Leong JM, Steere AC. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun. 1993;61:2774\u20139.","journal-title":"Infect Immun"},{"key":"701_CR59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/IAI.67.1.173-181.1999","volume":"67","author":"E Akin","year":"1999","unstructured":"Akin E, McHugh GL, Flavell RA, Fikrig E, Steere AC. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun. 1999;67:173\u201381.","journal-title":"Infect Immun"},{"key":"701_CR60","doi-asserted-by":"crossref","first-page":"e3211","DOI":"10.1371\/journal.pntd.0003211","volume":"8","author":"YE Castro-Sesquen","year":"2014","unstructured":"Castro-Sesquen YE, Gilman RH, Galdos-Cardenas G, Ferrufino L, S\u00e1nchez G, Valencia Ayala E, Liotta L, Bern C, Luchini A. Peru WGoCDiBa: use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease. PLoS Negl Trop Dis. 2014;8:e3211.","journal-title":"PLoS Negl Trop Dis"},{"key":"701_CR61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bjd.12855","volume":"171","author":"FC Brandt","year":"2014","unstructured":"Brandt FC, Ertas B, Falk TM, Metze D, B\u00f6er-Auer A. Genotyping of Borrelia from formalin-fixed paraffin-embedded skin biopsies of cutaneous borreliosis and tick bite reactions by assays targeting the intergenic spacer region, ospA and ospC genes. Br J Dermatol. 2014;171:528\u201343.","journal-title":"Br J Dermatol"},{"key":"701_CR62","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1542\/peds.91.2.456","volume":"91","author":"HM Feder","year":"1993","unstructured":"Feder HM, Gerber MA, Krause PJ, Ryan R, Shapiro ED. Early Lyme disease: a flu-like illness without erythema migrans. Pediatrics. 1993;91:456\u20139.","journal-title":"Pediatrics"},{"key":"701_CR63","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.ijid.2013.01.008","volume":"17","author":"JN Aucott","year":"2013","unstructured":"Aucott JN, Crowder LA, Kortte KB. Development of a foundation for a case definition of post-treatment Lyme disease syndrome. Int J Infect Dis. 2013;17:e443\u20139.","journal-title":"Int J Infect Dis"},{"key":"701_CR64","doi-asserted-by":"crossref","first-page":"e29914","DOI":"10.1371\/journal.pone.0029914","volume":"7","author":"ME Embers","year":"2012","unstructured":"Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, Jacobs MB, Hasenkampf NR, Martin DS, Narasimhan S, et al. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One. 2012;7:e29914.","journal-title":"PLoS One"},{"key":"701_CR65","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.01050-07","volume":"52","author":"E Hodzic","year":"2008","unstructured":"Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother. 2008;52:1728\u201336.","journal-title":"Antimicrob Agents Chemother"},{"key":"701_CR66","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/AAC.00788-09","volume":"54","author":"SW Barthold","year":"2010","unstructured":"Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother. 2010;54:643\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"701_CR67","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.micinf.2003.11.014","volume":"6","author":"ME Embers","year":"2004","unstructured":"Embers ME, Ramamoorthy R, Philipp MT. Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease. Microbes Infect. 2004;6:312\u20138.","journal-title":"Microbes Infect"},{"key":"701_CR68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tim.2007.06.003","volume":"15","author":"FC Cabello","year":"2007","unstructured":"Cabello FC, Godfrey HP, Newman SA. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol. 2007;15:350\u20134.","journal-title":"Trends Microbiol"},{"key":"701_CR69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/MMBR.55.1.21-34.1991","volume":"55","author":"A Szczepanski","year":"1991","unstructured":"Szczepanski A, Benach JL. Lyme borreliosis: host responses to Borrelia burgdorferi. Microbiol Rev. 1991;55:21\u201334.","journal-title":"Microbiol Rev"},{"key":"701_CR70","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1128\/IAI.71.9.5042-5055.2003","volume":"71","author":"E Hodzic","year":"2003","unstructured":"Hodzic E, Feng S, Freet KJ, Barthold SW. Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Infect Immun. 2003;71:5042\u201355.","journal-title":"Infect Immun"},{"key":"701_CR71","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM199203123261109","volume":"326","author":"AA Mahmoud","year":"1992","unstructured":"Mahmoud AA. The challenge of intracellular pathogens. N Engl J Med. 1992;326:761\u20132.","journal-title":"N Engl J Med"},{"key":"701_CR72","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1128\/AAC.40.6.1552","volume":"40","author":"P Brouqui","year":"1996","unstructured":"Brouqui P, Badiaga S, Raoult D. Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin. Antimicrob Agents Chemother. 1996;40:1552\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"701_CR73","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/infdis\/167.5.1074","volume":"167","author":"MS Klempner","year":"1993","unstructured":"Klempner MS, Noring R, Rogers RA. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis. 1993;167:1074\u201381.","journal-title":"J Infect Dis"},{"key":"701_CR74","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.micinf.2006.08.014","volume":"8","author":"JA Livengood","year":"2006","unstructured":"Livengood JA, Gilmore RD. Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi. Microbes Infect. 2006;8:2832\u201340.","journal-title":"Microbes Infect"},{"key":"701_CR75","doi-asserted-by":"crossref","first-page":"e48277","DOI":"10.1371\/journal.pone.0048277","volume":"7","author":"E Sapi","year":"2012","unstructured":"Sapi E, Bastian SL, Mpoy CM, Scott S, Rattelle A, Pabbati N, Poruri A, Burugu D, Theophilus PA, Pham TV, et al. Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS One. 2012;7:e48277.","journal-title":"PLoS One"},{"key":"701_CR76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(00)80206-8","volume":"89","author":"JR Zhang","year":"1997","unstructured":"Zhang JR, Hardham JM, Barbour AG, Norris SJ. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell. 1997;89:275\u201385.","journal-title":"Cell"},{"key":"701_CR77","doi-asserted-by":"crossref","first-page":"e1000293","DOI":"10.1371\/journal.ppat.1000293","volume":"5","author":"L Coutte","year":"2009","unstructured":"Coutte L, Botkin DJ, Gao L, Norris SJ. Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection. PLoS Pathog. 2009;5:e1000293.","journal-title":"PLoS Pathog"},{"key":"701_CR78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20011870","volume":"195","author":"FT Liang","year":"2002","unstructured":"Liang FT, Jacobs MB, Bowers LC, Philipp MT. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med. 2002;195:415\u201322.","journal-title":"J Exp Med"},{"key":"701_CR79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3201\/eid0605.000502","volume":"6","author":"AG Barbour","year":"2000","unstructured":"Barbour AG, Restrepo BI. Antigenic variation in vector-borne pathogens. Emerg Infect Dis. 2000;6:449\u201357.","journal-title":"Emerg Infect Dis"},{"key":"701_CR80","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF01713153","volume":"25","author":"O Brorson","year":"1997","unstructured":"Brorson O, Brorson SH. Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes. Infection. 1997;25:240\u20136.","journal-title":"Infection"},{"key":"701_CR81","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF02771839","volume":"26","author":"O Brorson","year":"1998","unstructured":"Brorson O, Brorson SH. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection. 1998;26:144\u201350.","journal-title":"Infection"},{"key":"701_CR82","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF01781096","volume":"24","author":"VP Mursic","year":"1996","unstructured":"Mursic VP, Wanner G, Reinhardt S, Wilske B, Busch U, Marget W. Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection. 1996;24:218\u201326.","journal-title":"Infection"},{"issue":"Suppl 1","key":"701_CR83","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/jobm.201000074","volume":"50","author":"S Al-Robaiy","year":"2010","unstructured":"Al-Robaiy S, Dihazi H, Kacza J, Seeger J, Schiller J, Huster D, Knauer J, Straubinger RK. Metamorphosis of Borrelia burgdorferi organisms\u2013RNA, lipid and protein composition in context with the spirochetes\u2019 shape. J Basic Microbiol. 2010;50(Suppl 1):S5\u201317.","journal-title":"J Basic Microbiol"},{"key":"701_CR84","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1086\/429632","volume":"191","author":"PH Duray","year":"2005","unstructured":"Duray PH, Yin SR, Ito Y, Bezrukov L, Cox C, Cho MS, Fitzgerald W, Dorward D, Zimmerberg J, Margolis L. Invasion of human tissue ex vivo by Borrelia burgdorferi. J Infect Dis. 2005;191:1747\u201354.","journal-title":"J Infect Dis"},{"key":"701_CR85","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.39.5.1127","volume":"39","author":"A Kersten","year":"1995","unstructured":"Kersten A, Poitschek C, Rauch S, Aberer E. Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob Agents Chemother. 1995;39:1127\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 1","key":"701_CR86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1099\/00221287-146-1-119","volume":"146","author":"PS Alban","year":"2000","unstructured":"Alban PS, Johnson PW, Nelson DR. Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology. 2000;146(Pt 1):119\u201327.","journal-title":"Microbiology"},{"key":"701_CR87","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-2094-5-40","volume":"5","author":"J Miklossy","year":"2008","unstructured":"Miklossy J, Kasas S, Zurn AD, McCall S, Yu S, McGeer PL. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation. 2008;5:40.","journal-title":"J Neuroinflammation"},{"key":"701_CR88","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1074\/jbc.M308343200","volume":"279","author":"P Kraiczy","year":"2004","unstructured":"Kraiczy P, Hellwage J, Skerka C, Becker H, Kirschfink M, Simon MM, Brade V, Zipfel PF, Wallich R. Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem. 2004;279:2421\u20139.","journal-title":"J Biol Chem"},{"key":"701_CR89","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.4049\/jimmunol.170.6.3214","volume":"170","author":"M Pausa","year":"2003","unstructured":"Pausa M, Pellis V, Cinco M, Giulianini PG, Presani G, Perticarari S, Murgia R, Tedesco F. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. J Immunol. 2003;170:3214\u201322.","journal-title":"J Immunol"},{"issue":"Suppl 33","key":"701_CR90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1438-4221(02)80027-3","volume":"291","author":"P Kraiczy","year":"2002","unstructured":"Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody. Int J Med Microbiol. 2002;291(Suppl 33):141\u20136.","journal-title":"Int J Med Microbiol"},{"key":"701_CR91","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.micinf.2007.10.004","volume":"10","author":"P Hartiala","year":"2008","unstructured":"Hartiala P, Hyt\u00f6nen J, Suhonen J, Lepp\u00e4ranta O, Tuominen-Gustafsson H, Viljanen MK. Borrelia burgdorferi inhibits human neutrophil functions. Microbes Infect. 2008;10:60\u20138.","journal-title":"Microbes Infect"},{"key":"701_CR92","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1189\/jlb.1106709","volume":"82","author":"P Hartiala","year":"2007","unstructured":"Hartiala P, Hyt\u00f6nen J, Pelkonen J, Kimppa K, West A, Penttinen MA, Suhonen J, Lahesmaa R, Viljanen MK. Transcriptional response of human dendritic cells to Borrelia garinii\u2013defective CD38 and CCR7 expression detected. J Leukoc Biol. 2007;82:33\u201343.","journal-title":"J Leukoc Biol"},{"key":"701_CR93","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.nbd.2009.11.016","volume":"37","author":"BA Fallon","year":"2010","unstructured":"Fallon BA, Levin ES, Schweitzer PJ, Hardesty D. Inflammation and central nervous system Lyme disease. Neurobiol Dis. 2010;37:534\u201341.","journal-title":"Neurobiol Dis"},{"key":"701_CR94","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/IAI.01404-07","volume":"76","author":"JJ Lazarus","year":"2008","unstructured":"Lazarus JJ, Kay MA, McCarter AL, Wooten RM. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun. 2008;76:1153\u201362.","journal-title":"Infect Immun"},{"key":"701_CR95","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1128\/IAI.66.6.2691-2697.1998","volume":"66","author":"GH Giambartolomei","year":"1998","unstructured":"Giambartolomei GH, Dennis VA, Philipp MT. Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect Immun. 1998;66:2691\u20137.","journal-title":"Infect Immun"},{"key":"701_CR96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-1119(02)01146-0","volume":"303","author":"ML Sartakova","year":"2003","unstructured":"Sartakova ML, Dobrikova EY, Terekhova DA, Devis R, Bugrysheva JV, Morozova OV, Godfrey HP, Cabello FC. Novel antibiotic-resistance markers in pGK12-derived vectors for Borrelia burgdorferi. Gene. 2003;303:131\u20137.","journal-title":"Gene"},{"key":"701_CR97","first-page":"72","volume":"106","author":"R Nau","year":"2009","unstructured":"Nau R, Christen HJ, Eiffert H. Lyme disease\u2013current state of knowledge. Dtsch Arztebl Int. 2009;106:72\u201381 (quiz 82, I).","journal-title":"Dtsch Arztebl Int"},{"key":"701_CR98","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1056\/NEJMcp061181","volume":"354","author":"GP Wormser","year":"2006","unstructured":"Wormser GP. Clinical practice. Early Lyme disease. N Engl J Med. 2006;354:2794\u2013801.","journal-title":"N Engl J Med"},{"key":"701_CR99","unstructured":"(CDC) CfDCaP: Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995; 44:590\u2013591."},{"key":"701_CR100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/JCM.33.2.419-427.1995","volume":"33","author":"SM Engstrom","year":"1995","unstructured":"Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol. 1995;33:419\u201327.","journal-title":"J Clin Microbiol"},{"key":"701_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.34.1.1-9.1996","volume":"34","author":"ME Aguero-Rosenfeld","year":"1996","unstructured":"Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34:1\u20139.","journal-title":"J Clin Microbiol"},{"key":"701_CR102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0190-9622(95)90130-2","volume":"32","author":"J Nowakowski","year":"1995","unstructured":"Nowakowski J, Nadelman RB, Forseter G, McKenna D, Wormser GP. Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans. J Am Acad Dermatol. 1995;32:223\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"701_CR103","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461\u201373.","journal-title":"Lancet"},{"key":"701_CR104","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ijpara.2008.03.001","volume":"38","author":"KP Hunfeld","year":"2008","unstructured":"Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol. 2008;38:1219\u201337.","journal-title":"Int J Parasitol"},{"key":"701_CR105","first-page":"1851","volume":"160","author":"CC Santos dos","year":"1999","unstructured":"dos Santos CC, Kain KC. Two tick-borne diseases in one: a case report of concurrent babesiosis and Lyme disease in Ontario. CMAJ. 1999;160:1851\u20133.","journal-title":"CMAJ"},{"key":"701_CR106","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/322681","volume":"33","author":"C Thompson","year":"2001","unstructured":"Thompson C, Spielman A, Krause PJ. Coinfecting deer-associated zoonoses: lyme disease, babesiosis, and ehrlichiosis. Clin Infect Dis. 2001;33:676\u201385.","journal-title":"Clin Infect Dis"},{"key":"701_CR107","first-page":"197","volume":"70","author":"ME Aguero-Rosenfeld","year":"2003","unstructured":"Aguero-Rosenfeld ME. Laboratory aspects of tick-borne diseases: lyme, human granulocytic ehrlichiosis and babesiosis. Mt Sinai J Med. 2003;70:197\u2013206.","journal-title":"Mt Sinai J Med"},{"issue":"Suppl 2","key":"701_CR108","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1469-0691.2008.02145.x","volume":"15","author":"S Lotric-Furlan","year":"2009","unstructured":"Lotric-Furlan S, Ruzic-Sabljic E, Strle F. Concomitant human granulocytic anaplasmosis and Lyme neuroborreliosis. Clin Microbiol Infect. 2009;15(Suppl 2):28\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"701_CR109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.vetpar.2009.09.016","volume":"167","author":"B Doudier","year":"2010","unstructured":"Doudier B, Olano J, Parola P, Brouqui P. Factors contributing to emergence of Ehrlichia and Anaplasma spp. as human pathogens. Vet Parasitol. 2010;167:149\u201354.","journal-title":"Vet Parasitol"},{"key":"701_CR110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3201\/eid0402.980222","volume":"4","author":"DJ Sexton","year":"1998","unstructured":"Sexton DJ, Corey GR, Carpenter C, Kong LQ, Gandhi T, Breitschwerdt E, Hegarty B, Chen SM, Feng HM, Yu XJ, et al. Dual infection with Ehrlichia chaffeensis and a spotted fever group rickettsia: a case report. Emerg Infect Dis. 1998;4:311\u20136.","journal-title":"Emerg Infect Dis"},{"key":"701_CR111","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.pt.2012.07.003","volume":"28","author":"F Dantas-Torres","year":"2012","unstructured":"Dantas-Torres F, Chomel BB, Otranto D. Ticks and tick-borne diseases: a one health perspective. Trends Parasitol. 2012;28:437\u201346.","journal-title":"Trends Parasitol"},{"key":"701_CR112","first-page":"18","volume":"2012","author":"D Raoult","year":"1919","unstructured":"Raoult D. Bartonella spp. Bacteremia and rheumatic symptoms in patients from lyme disease-endemic region. Emerg Infect Dis. 1919;2012:18.","journal-title":"Emerg Infect Dis"},{"key":"701_CR113","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1749-6632.2003.tb07400.x","volume":"990","author":"E Podsiad\u0142y","year":"2003","unstructured":"Podsiad\u0142y E, Chmielewski T, Tylewska-Wierzbanowska S. Bartonella henselae and Borrelia burgdorferi infections of the central nervous system. Ann N Y Acad Sci. 2003;990:404\u20136.","journal-title":"Ann N Y Acad Sci"},{"key":"701_CR114","first-page":"988","volume":"129","author":"EAM Sapi","year":"2008","unstructured":"Sapi EAM. Biofilms of Borrelia burgdorferi in chronic cutaneous borreliosis. Am J Clin Pathol. 2008;129:988\u20139.","journal-title":"Am J Clin Pathol"},{"key":"701_CR115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IJGM.S44114","volume":"6","author":"K Berndtson","year":"2013","unstructured":"Berndtson K. Review of evidence for immune evasion and persistent infection in Lyme disease. Int J Gen Med. 2013;6:291\u2013306.","journal-title":"Int J Gen Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0701-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T05:00:15Z","timestamp":1653454815000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0701-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]},"article-number":"346"}}